Ursula Amstutz

Creation of the Swiss group of Pharmacogenomics and personalised Therapy (SPT)

Pierre Baumann, Caroline Samer, Ursula Amstutz, 2017, Drug metabolism and personalized therapy.

Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity.

Ursula Amstutz, U. Amstutz, C. Largiadèr, 2011, Pharmacogenomics.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update

Julia M. Barbarino, Ursula Amstutz, T. Klein, 2018, Clinical pharmacology and therapeutics.

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use

Naomi Porret, Ursula Amstutz, U. Amstutz, 2018, Blood Cancer Journal.

Pharmacogenomics of Cardiovascular Drugs and Adverse Effects in Pediatrics

Ursula Amstutz, Johanna Sistonen, M. Hayden, 2011, Journal of cardiovascular pharmacology.

Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy

Jacques Turgeon, Shinya Ito, Lawrence J Lesko, 2015, Therapeutic drug monitoring.